Switch theme
Sign up to access all valuation multiples
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
1923
10.6K+
LTM Revenue $2.9B
LTM EBITDA $723M
$15.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
West Pharma has a last 12-month revenue of $2.9B and a last 12-month EBITDA of $723M.
In the most recent fiscal year, West Pharma achieved revenue of $2.9B and an EBITDA of $744M.
West Pharma expects next 12-month revenue of XXX and NTM EBITDA of XXX
See West Pharma valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $2.9B | $2.9B | XXX | XXX | XXX |
| Gross Profit | $1.1B | $1.1B | XXX | XXX | XXX |
| Gross Margin | 39% | 39% | XXX | XXX | XXX |
| EBITDA | $844M | $744M | XXX | XXX | XXX |
| EBITDA Margin | 29% | 26% | XXX | XXX | XXX |
| Net Profit | $586M | $593M | XXX | XXX | XXX |
| Net Margin | 20% | 21% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, West Pharma's stock price is $213.
West Pharma has current market cap of $15.4B, and EV of $15.2B.
See West Pharma trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $15.2B | $15.4B | XXX | XXX | XXX | XXX | $6.57 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, West Pharma has market cap of $15.4B and EV of $15.2B.
West Pharma's trades at 5.2x LTM EV/Revenue multiple, and 21.0x LTM EBITDA.
Analysts estimate West Pharma's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for West Pharma and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $15.2B | XXX | XXX | XXX |
| EV/Revenue | 5.3x | XXX | XXX | XXX |
| EV/EBITDA | 20.4x | XXX | XXX | XXX |
| P/E | 31.2x | XXX | XXX | XXX |
| P/E/Growth | 25.2x | XXX | XXX | XXX |
| EV/FCF | 55.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpWest Pharma's NTM/LTM revenue growth is 2%
West Pharma's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $38K for the same period.
Over next 12 months, West Pharma's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate West Pharma's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for West Pharma and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -2% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -12% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 28% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $38K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 14% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
| Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
| Schott Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Fresenius Medical Care | XXX | XXX | XXX | XXX | XXX | XXX |
| Fresenius | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
West Pharma acquired XXX companies to date.
Last acquisition by West Pharma was XXXXXXXX, XXXXX XXXXX XXXXXX . West Pharma acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was West Pharma founded? | West Pharma was founded in 1923. |
| Where is West Pharma headquartered? | West Pharma is headquartered in United States of America. |
| How many employees does West Pharma have? | As of today, West Pharma has 10.6K+ employees. |
| Who is the CEO of West Pharma? | West Pharma's CEO is Mr. Eric Mark Green. |
| Is West Pharma publicy listed? | Yes, West Pharma is a public company listed on NYS. |
| What is the stock symbol of West Pharma? | West Pharma trades under WST ticker. |
| When did West Pharma go public? | West Pharma went public in 1980. |
| Who are competitors of West Pharma? | Similar companies to West Pharma include e.g. Ansell, Polymed, Schott Pharma, Fresenius Medical Care. |
| What is the current market cap of West Pharma? | West Pharma's current market cap is $15.4B |
| What is the current revenue of West Pharma? | West Pharma's last 12-month revenue is $2.9B. |
| What is the current EBITDA of West Pharma? | West Pharma's last 12-month EBITDA is $723M. |
| What is the current EV/Revenue multiple of West Pharma? | Current revenue multiple of West Pharma is 5.2x. |
| What is the current EV/EBITDA multiple of West Pharma? | Current EBITDA multiple of West Pharma is 21.0x. |
| What is the current revenue growth of West Pharma? | West Pharma revenue growth between 2023 and 2024 was -2%. |
| Is West Pharma profitable? | Yes, West Pharma is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
